Crop health company Enko raises $80 million

Enko, the crop health company, announced that it has raised additional funding from our Eight Roads Ventures India teams, Nufarm, Endeavor8, and Akroyd LLC. This raise, brings the company's overall capital raised to date to $150 million.

Enko will use the new funds to advance the company’s product pipeline of novel crop protection chemistries and provide critical solutions for large scale global food security challenges.

Since its start in 2017, Enko has generated hundreds of leading molecules across all categories of crop protection through its ENKOMPASSTM technology platform, which combines DNA-encoded library screening with machine learning and structure-based design to quickly find new, better performing and more targeted chemistries. Enko's product pipeline is currently led by a range of herbicides that are breaking cycles of weed and pest resistance and are being developed to reduce environmental load compared to current solutions.

"We are thrilled to have the additional support of Eight Roads Ventures, Nufarm, Endeavor8, and Akroyd LLC, as we continue to advance our product pipeline," said Jacqueline Heard, CEO of Enko. "These funds will help us to amplify our efforts to bring effective new crop protection solutions to market. Farmers worldwide are struggling with mounting challenges exacerbated by climate change. Enko is working to help growers cost-effectively adapt and mitigate some of the key challenges to the food chain around the world: pesticide-resistant weeds, fungus, and pests.”

Read the press coverage here

 

 

By investing in better crop protection, we can help improve yields, reduce waste, and create more sustainable food systems for our growing population in an increasingly unstable world.
Dr. Prem Pavoor, Senior Partner, Head of India & Healthcare Investments, Eight Roads Ventures
Share

The information on these pages is intended solely for the benefit of entrepreneurs and businesses seeking venture capital investment. Eight Roads does not offer and is not offering to provide investment advisory services nor is it offering to engage in any transactions in securities.